CB:NYSEChubb Limited Analysis

Chubb (CB) trades at $324.4, roughly 4% below the DCF‑derived fair value of $496, indicating a sizable upside. The stock sits just above the identified support of $321.75 and below its 20‑day SMA of $332, suggesting short‑term pressure. Technicals show a bearish MACD histogram (‑1.91) and a neutral RSI at 45.9, reinforcing caution on the near‑term. Nonetheless, the broader trend remains bullish, with the 50‑day SMA ($318.5) and 200‑day SMA ($292.4) both well under the current price. Fundamentals are robust: revenue grew 5.5% YoY to $59.6 bn, operating margin stands at 24.2% and free cash flow exceeds $12 bn. The company’s PE of 12.6 is well under the industry average of 17.4, and its payout ratio is a modest 15%, supporting dividend sustainability.
Analysts are overwhelmingly positive, with 23 forecasts averaging a target of $338 and recent upgrades from BMO, Roth Capital and Citi pushing objectives to $326‑$385. The board’s 33rd consecutive dividend increase underscores confidence in cash generation. Low beta (0.26) and a modest 30‑day volatility of 21% point to defensive characteristics. The balance sheet shows ample liquidity ($7.1 bn cash) against $24.7 bn debt, yielding a debt‑to‑equity of 31, manageable for an insurer. The stock’s upside potential of roughly 4% per the DCF model, combined with a dividend yield of 1.18%, makes it attractive for income‑oriented investors. In this context, the recommendation leans toward buying for medium‑to‑long horizons while remaining watchful of near‑term technical headwinds.